Advice
Following an abbreviated submission
desmopressin oral lyophilisate (DDAVP Melt®) is accepted for use in NHS Scotland for the treatment of vasopressin-sensitive cranial diabetes insipidus and in the treatment of post-hypophysectomy polyuria/polydipsia.
In patients for whom desmopressin is an appropriate choice of therapy, it offers a sublingual formulation at an equivalent cost to a clinically equivalent dose in a solid oral dose formulation.
Download detailed advice26KB (PDF)
Medicine details
- Medicine name:
- desmopressin 60, 120 and 240 micrograms oral lyophilisate (DDAVP Melt)
- SMC ID:
- 358/07
- Indication:
- Vasopressin-sensitive cranial diabetes insipidus/post-hypophysectomy polyuria/polydipsia
- Pharmaceutical company
- Ferring Pharmaceuticals Ltd
- BNF chapter
- Endocrine system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 07 May 2007